Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidemic Meningitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03493919
What this trial is testing

A Sourcing Study to Collect Human Blood Samples From Healthy Adults

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,021
Early research (Phase 1)Study completedNCT04236960
What this trial is testing

Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population.

Who this might be right for
Meningococcal Infections
Walvax Biotechnology Co., Ltd. 100
Early research (Phase 1)Looking for participantsNCT07203755
What this trial is testing

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

Who this might be right for
Diphtheria, Tetanus and Acellular PertussisEpidemic MeningitisHaemophilus Influenzae Type B Infection
CanSino Biologics Inc. 260
Testing effectiveness (Phase 2)Study completedNCT00310817
What this trial is testing

Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.

Who this might be right for
Meningococcal Meningitis
Novartis Vaccines 623
Large-scale testing (Phase 3)Study completedNCT00329901
What this trial is testing

Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,072
Not applicableUnknownNCT05348707
What this trial is testing

Impact of Covid-19 on Rhinovirus Epidemic

Who this might be right for
Rhinovirus
Hospices Civils de Lyon 400
Early research (Phase 1)Study completedNCT00248833
What this trial is testing

Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis.

Who this might be right for
Meningitis, Meningococcal, Serogroup B
U.S. Army Medical Research and Development Command 34
Large-scale testing (Phase 3)UnknownNCT02858570
What this trial is testing

Conjugate Vaccine Against Meningococcus C a Brazilian Project

Who this might be right for
Serogroup C Meningococcal Meningitis
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 1,644
Post-approval studies (Phase 4)UnknownNCT00262015
What this trial is testing

Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine

Who this might be right for
Meningococcal Disease; Meningococcal Meningitis
Chiron Corporation 264
Testing effectiveness (Phase 2)Study completedNCT00808028
What this trial is testing

A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents

Who this might be right for
Meningitis, Meningococcal
Pfizer 538
Large-scale testing (Phase 3)Looking for participantsNCT07505823
What this trial is testing

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months

Who this might be right for
Epidemic MeningitisMeningococcal Vaccines
Sinovac Biotech Co., Ltd 1,040
Large-scale testing (Phase 3)Study completedNCT06011200
What this trial is testing

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population

Who this might be right for
Epidemic Meningitis
CanSino Biologics Inc. 1,000
Large-scale testing (Phase 3)Study completedNCT01214837
What this trial is testing

Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 751
Large-scale testing (Phase 3)Study completedNCT00856297
What this trial is testing

Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine

Who this might be right for
Meningococcal Meningitis
Novartis Vaccines 389
Large-scale testing (Phase 3)Study completedNCT00384397
What this trial is testing

2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,128
Large-scale testing (Phase 3)Study completedNCT01519713
What this trial is testing

Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 200
Large-scale testing (Phase 3)Study completedNCT02955797
What this trial is testing

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 918
Early research (Phase 1)UnknownNCT02878291
What this trial is testing

Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months

Who this might be right for
Meningitis, Meningococcal
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 200
Testing effectiveness (Phase 2)Study completedNCT01768117
What this trial is testing

Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age

Who this might be right for
Meningitis, Meningococcal, Serogroup B
Pfizer 13
Not applicableStudy completedNCT02699840
What this trial is testing

Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 100
Next Page